Pharmaceutical

AbbVie and EvolveImmune Therapeutics sign oncology collaboration

AbbVie has entered into a partnership and option-to-license agreement with EvolveImmune Therapeutics, to develop next-generation cancer biotherapeutics.

Nov 3, 2024 - 06:00
AbbVie and EvolveImmune Therapeutics sign oncology collaboration
AbbVie has entered into a partnership and option-to-license agreement with EvolveImmune Therapeutics, to develop next-generation cancer biotherapeutics.
Read the original article

Tags:

Previous Article

US court upholds Avadel’s narcolepsy drug approval amid exclusivity battle 

Next Article

EC fines Teva $502m over multiple sclerosis treatment Copaxone practices

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

An ugly fight over care for the poor in Texas

An ugly fight over care for the poor in Texas

Jan 2, 2024

Q3 2023 update: social responsibility related hiring ac...

Oct 19, 2023

Policy experts call on Medicare to ensure data from Alzheimer’s drug registries is shared publicly

Policy experts call on Medicare to ensure data from Alz...

Jul 28, 2023